$38M sweet spot round size
Most of their 18 investments are in rounds between $14M and $120M
2008
HeartFlow, Inc raised $215M on April 6, 2023
Investors: Capricorn Investment Group, Hayfin Capital Management LLP, Baillie Gifford, Wellington Management, Martis Capital and HEALTHCOR LTD
Karyopharm Therapeutics Inc. raised $165M on December 5, 2022
Investors: Adage Capital Management, Armistice Capital LLC, Surveyor Capital, Marshall Wace, Avidity Partners and HEALTHCOR LTD
Mineralys Therapeutics, Inc. raised $118M on June 8, 2022
Investors: Sectoral Asset Management, Samsara BioCapital, Catalys Pacific, S.R. One Ltd, RA Capital Management, L.P., Ysios Capital, RTW Investments, LP and HEALTHCOR LTD
DNA Script raised $200M on January 4, 2022
Investors: T. Rowe Price, Casdin Capital, LLC, HealthCor Management, L.P., eureKARE, Irving Investors, Coatue Management, Catalio Capital Management, Columbia Threadneedle Investments EMEA APAC and HEALTHCOR LTD
Imperative Care raised $260M on July 15, 2021
Investors: Amed Ventures, Delos Capital, Ascension Ventures, Innovatus Capital Partners, D1 Capital Partners L.P. and HEALTHCOR LTD
Kyn Therapeutics raised $120M on January 5, 2021
Investors: Omega Funds, Farallon Capital Management, OrbiMed Advisors, Surveyor Capital, Logos Global Management, LP, The Invus Group and HEALTHCOR LTD
Claret Medical now a part of Boston Scientific raised $15M on October 23, 2017
Investors: Easton Capital Investment Group, Lightstone Ventures, - and HEALTHCOR LTD
Undisclosed raised undisclosed on October 1, 2015
Investors: HEALTHCOR LTD
HLS Therapeutics Inc. raised $30M on August 26, 2015
Investors: HEALTHCOR LTD
ReShape Lifesciences Inc. raised $38M on August 26, 2015
Investors: New Leaf Venture Partners, Venture Investors, SV Life Sciences, Endeavour Vision and HEALTHCOR LTD